These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
483 related articles for article (PubMed ID: 16481328)
1. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. Hashemy SI; Ungerstedt JS; Zahedi Avval F; Holmgren A J Biol Chem; 2006 Apr; 281(16):10691-7. PubMed ID: 16481328 [TBL] [Abstract][Full Text] [Related]
2. The thioredoxin antioxidant system. Lu J; Holmgren A Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494 [TBL] [Abstract][Full Text] [Related]
3. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. Fang J; Lu J; Holmgren A J Biol Chem; 2005 Jul; 280(26):25284-90. PubMed ID: 15879598 [TBL] [Abstract][Full Text] [Related]
4. The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy. Biaglow JE; Miller RA Cancer Biol Ther; 2005 Jan; 4(1):6-13. PubMed ID: 15684606 [TBL] [Abstract][Full Text] [Related]
5. Thioredoxin reductase from Bacillus cereus exhibits distinct reduction and NADPH-binding properties. Shoor M; Gudim I; Hersleth HP; Hammerstad M FEBS Open Bio; 2021 Nov; 11(11):3019-3031. PubMed ID: 34492167 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase. Zahedi Avval F; Holmgren A J Biol Chem; 2009 Mar; 284(13):8233-40. PubMed ID: 19176520 [TBL] [Abstract][Full Text] [Related]
7. Mechanistic characterization of the thioredoxin system in the removal of hydrogen peroxide. Pannala VR; Dash RK Free Radic Biol Med; 2015 Jan; 78():42-55. PubMed ID: 25451645 [TBL] [Abstract][Full Text] [Related]
8. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol. Huang J; Xu J; Tian L; Zhong L Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd). Zahedi Avval F; Berndt C; Pramanik A; Holmgren A Biochem Biophys Res Commun; 2009 Feb; 379(3):775-9. PubMed ID: 19121624 [TBL] [Abstract][Full Text] [Related]
10. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Zhao R; Masayasu H; Holmgren A Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8579-84. PubMed ID: 12070343 [TBL] [Abstract][Full Text] [Related]
11. Glutathione-dependent thioredoxin reduction and lipoamide system support in-vitro mammalian ribonucleotide reductase catalysis: a possible antioxidant redundancy. Chatterji A; Sachin K; Sengupta R Mol Biol Rep; 2022 Aug; 49(8):8179-8183. PubMed ID: 35655055 [TBL] [Abstract][Full Text] [Related]
12. Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase. Björnstedt M; Kumar S; Holmgren A J Biol Chem; 1992 Apr; 267(12):8030-4. PubMed ID: 1569062 [TBL] [Abstract][Full Text] [Related]
13. Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. Kumar S; Björnstedt M; Holmgren A Eur J Biochem; 1992 Jul; 207(2):435-39. PubMed ID: 1321713 [TBL] [Abstract][Full Text] [Related]
14. Functional analyses of ancestral thioredoxins provide insights into their evolutionary history. Napolitano S; Reber RJ; Rubini M; Glockshuber R J Biol Chem; 2019 Sep; 294(38):14105-14118. PubMed ID: 31366732 [TBL] [Abstract][Full Text] [Related]
15. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples. Montano SJ; Lu J; Gustafsson TN; Holmgren A Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250 [TBL] [Abstract][Full Text] [Related]
16. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction. Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472 [TBL] [Abstract][Full Text] [Related]
17. Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic. Ren X; Zou L; Lu J; Holmgren A Free Radic Biol Med; 2018 Nov; 127():238-247. PubMed ID: 29807162 [TBL] [Abstract][Full Text] [Related]
18. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy. Tonissen KF; Di Trapani G Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503 [TBL] [Abstract][Full Text] [Related]
19. Thioredoxin reductase as a pharmacological target. Bjørklund G; Zou L; Wang J; Chasapis CT; Peana M Pharmacol Res; 2021 Dec; 174():105854. PubMed ID: 34455077 [TBL] [Abstract][Full Text] [Related]
20. Thioredoxin reductase-thioredoxin fusion enzyme from Mycobacterium leprae: comparison with the separately expressed thioredoxin reductase. Wang PF; Marcinkeviciene J; Williams CH; Blanchard JS Biochemistry; 1998 Nov; 37(46):16378-89. PubMed ID: 9819230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]